Prevention of tuberculosis reactivation
Brett K, Severn M
Record ID 32018002248
English
Authors' objectives:
Questions:
- What is the clinical utility of screening for latent tuberculosis infection in people at risk of tuberculosis reactivation?
- What is the clinical effectiveness of treating latent tuberculosis infection to prevent tuberculosis reactivation?
- What are the evidence-based guidelines for the prevention of tuberculosis reactivation?
Details
Project Status:
Completed
URL for project:
https://www.cadth.ca/prevention-tuberculosis-reactivation
Year Published:
2021
URL for published report:
https://cadth.ca/sites/default/files/pdf/htis/2021/RC1344%20Prevention%20of%20TB%20Reactivation%20Final.pdf
URL for additional information:
https://cadth.ca/tuberculosis
English language abstract:
An English language summary is available
Publication Type:
Rapid Review
Country:
Canada
MeSH Terms
- Tuberculosis
- Disease Susceptibility
- Latent Tuberculosis
- Preventive Medicine
- Health Promotion
Keywords
- Tuberculosis
- Health promotion
- Reactivation
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
<p>Canadian Agency for Drugs and Technologies in Health (CADTH)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.